PHARMACODYNAMICS OF CYTOSINE-ARABINOSIDE (ARA2C) IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND RESULTS OF THERAPY

被引：0
|
作者：
VANPROOIJEN, HC [1 ]
VANDERKLEYN, E [1 ]
HAANEN, C [1 ]
机构：
[1] CATHOLIC UNIV NIJMEGEN,DEPT INTERNAL MED,DIV HAEMATOL,NIJMEGEN,NETHERLANDS
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1977年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：673 / 674
页数：2
相关论文
共 50 条
  • [31] REVIEW OF CLINICAL AND HEMATOLOGICAL RESPONSE TO LOW-DOSE CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA
    SHTALRID, M
    LOTEM, J
    SACHS, L
    BERREBI, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (01) : 3 - 11
  • [32] COMBINATION CHEMOTHERAPY FOR ADULT ACUTE MYELOID-LEUKEMIA WITH MITOXANTRONE, CYTOSINE-ARABINOSIDE AND VP-16
    LINK, H
    FREUND, M
    DIEDRICH, H
    WILKE, H
    HENKE, M
    HECHT, T
    WANDT, H
    KUSE, R
    CALAVREZOS, A
    POLIWODA, H
    BLUT, 1987, 55 (04): : 214 - 214
  • [33] CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - THE ROLE AND PLACE OF HIGH-DOSE REGIMENS
    HIDDEMANN, W
    ANNALS OF HEMATOLOGY, 1991, 62 (04) : 119 - 128
  • [34] TREATMENT OF REFRACTORY ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE IN COMBINATION
    HIDDEMANN, W
    KREUTZMANN, H
    LUDWIG, WD
    AUL, HC
    DONHUIJSENANT, R
    LENGFELDER, E
    BUCHNER, T
    LEUKEMIA RESEARCH, 1986, 10 (01) : 110 - 110
  • [35] LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIA
    MAIOLO, AT
    FOA, P
    CORTELLARO, M
    LAMBERTENGHIDELILIERS, G
    COLANTONI, A
    CESANA, B
    CASTOLDI, GL
    CAZZOLA, M
    GIORDANO, M
    RICCARDI, A
    POLLI, EE
    HAEMATOLOGICA, 1987, 72 (01) : 61 - 65
  • [36] LOW-DOSE CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA - REMISSION IS NOT DUE TO DIFFERENTIATION INDUCTION
    PINKERTON, PH
    LONDON, B
    COWAN, DH
    AMERICAN JOURNAL OF HEMATOLOGY, 1985, 19 (04) : 415 - 417
  • [37] HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN INDUCTION PROLONGS REMISSION IN ACUTE MYELOID-LEUKEMIA (AML) - UPDATED RESULTS OF A RANDOMIZED PHASE-III TRIAL
    BISHOP, JF
    MATTHEWS, JP
    YOUNG, GA
    SZER, J
    GILLETT, A
    JOSHUA, D
    BRADSTOCK, K
    ENNO, A
    WOLF, M
    FOX, R
    COBCROFT, R
    HERRMANN, R
    VANDERWEYDEN, M
    JUNEJA, S
    BLOOD, 1994, 84 (10) : A232 - A232
  • [38] ACLARUBICIN PLUS CYTOSINE-ARABINOSIDE VERSUS DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A DANISH NATIONAL PHASE-III TRIAL
    HANSEN, OP
    PEDERSENBJERGAARD, J
    ELLEGAARD, J
    BRINCKER, H
    BOESEN, AM
    CHRISTENSEN, BE
    DRIVSHOLM, A
    HIPPE, E
    JANS, H
    JENSEN, KB
    KILLMANN, SA
    JENSEN, MK
    KARLE, H
    LAURSEN, B
    NIELSEN, JB
    NISSEN, NI
    THORLING, K
    LEUKEMIA, 1991, 5 (06) : 510 - 516
  • [39] LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE-LEUKEMIA
    WINTER, JN
    VARIAKOJIS, D
    GAYNOR, ER
    LARSON, RA
    MILLER, KB
    CANCER, 1985, 56 (03) : 443 - 449
  • [40] CORRELATION OF CYTOSINE-ARABINOSIDE (ARA-C) PHARMACOKINETICS, ARA-C PHOSPHORYLATION, INTRACELLULAR ARA-CTP HALF-LIFE AND EFFECTS ON DNA-SYNTHESIS IN ACUTE MYELOID-LEUKEMIA
    HARRIS, AL
    GRAHAMESMITH, DG
    BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 284 - 284
12345